Abstract
N-Isopropyl-α-(2-methylhydrazino)-p-toluamide inhibited the incorporation of thymidine-3H, deoxycytidine-3H, formate-14C, adenine-8-14C, and 4-amino-5-imidazolecarboxamide-2-14C into DNA, and the utilization of orotic acid-6-14C and leucine-1-14C for the synthesis of RNA and protein, respectively, in L5178Y lymphoma cells. The site of the drug-induced blockade of the formation of DNA did not appear to reside at the level of thymidine kinase (ATP:thymidine 5'-phosphotransferase, EC 2.7.1.21), thymidine monophosphate kinase (ATP:thymidine monophosphate phosphotransferase, EC 2.7.4.9), or DNA nucleotidyltransferase (deoxynucleosidetriphosphate:DNA deoxynucleotidyltransferase, EC 2.7.7.7). Furthermore, treatment of cells with N-isopropyl-α-(2-methylhydrazino)-p-toluamide did not influence the rate of loss of thymine-3H from prelabeled DNA. Possible metabolic alterations which might explain the observed results are discussed. The inhibitions of the syntheses of nucleic acids and proteins that were measured were followed by a period during which most of the cell death occurred; this period corresponded with the development of a metabolic imbalance that was characterized by an accumulation of RNA and protein and an increase in cell volume.
ACKNOWLEDGMENTS The authors wish to thank Dr. W. E. Scott, Hoffmann-La Roche, Inc. for a generous supply of MIH and Miss Sheila J. Feld for excellent technical assistance. This investigation was supported by USPHS Research Grant CA-02817 from the National Cancer Institute and by Grants ACS IN-31E-806 and ACS IN-31F-905 from the American Cancer Society. One of us (S.T.) gratefully acknowledges postdoctoral support from the Anna Fuller Fund.
- Copyright ©, 1966, by Academic Press Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|